Biotech Investors & VC Firms in Middle East & North Africa
11 firms in this list, with a median first check of $1M. 1 of them lead rounds. Generated from verified public data and updated continuously.
JAFCO Group
TokyoPre-Seed–Late Stage$1.9M – $198M
8 people
Impact Fund Denmark
Copenhagen KSeed–Late Stage$2.2M – $70.2M
11 people
Diffusion Capital Partners
IstanbulPre-Seed–Series A$439K – $2.7M
6 people
SBI Investment
TokyoPre-Seed–Growth$2M – $227M
1 person
Hyundai Venture Investment Corporation
SeoulSeed–Series B$5K – $16M
4 people
MSA Capital
George Town, Grand CaymanPre-Seed–Late Stage$1.4M – $130M
2 people
Trendlines Group
M.P. MisgavSeed–Late Stage$650K – $15M
1 person
Fubon Financial Holdings
TaipeiSeries A–Series B$5M – $27M
Israel Innovation Authority
JerusalemPre-Seed–Series A$140K – $5M
TRANGELS
IstanbulPre-Seed–Seed$24K – $1.4M
Asbis
Limassol
Related lists
Crypto & Web3 Investors & VC Firms (4307)Investors & VC Firms in United States (3280)SaaS Investors & VC Firms (2515)Enterprise Software Investors & VC Firms (1852)Fintech Investors & VC Firms (1781)Healthtech Investors & VC Firms (1705)Consumer Investors & VC Firms (1446)Investors & VC Firms in Europe (1444)Investors & VC Firms in Global (1401)Biotech Investors & VC Firms (1325)
Data sourced from public filings and firms' own websites — see our methodology.
